ATE443158T1 - Vektorvermittelte organellentransfektion - Google Patents

Vektorvermittelte organellentransfektion

Info

Publication number
ATE443158T1
ATE443158T1 AT02797288T AT02797288T ATE443158T1 AT E443158 T1 ATE443158 T1 AT E443158T1 AT 02797288 T AT02797288 T AT 02797288T AT 02797288 T AT02797288 T AT 02797288T AT E443158 T1 ATE443158 T1 AT E443158T1
Authority
AT
Austria
Prior art keywords
organelle
vector
mediated
viral
receptor
Prior art date
Application number
AT02797288T
Other languages
English (en)
Inventor
Shaharyar M Khan
Original Assignee
Univ Virginia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Virginia filed Critical Univ Virginia
Application granted granted Critical
Publication of ATE443158T1 publication Critical patent/ATE443158T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8214—Plastid transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2795/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/65—Vectors comprising as targeting moiety peptide derived from defined protein from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
AT02797288T 2001-12-13 2002-12-12 Vektorvermittelte organellentransfektion ATE443158T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34033801P 2001-12-13 2001-12-13
PCT/US2002/039745 WO2003052067A2 (en) 2001-12-13 2002-12-12 Vector mediated organelle transfection

Publications (1)

Publication Number Publication Date
ATE443158T1 true ATE443158T1 (de) 2009-10-15

Family

ID=23332914

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02797288T ATE443158T1 (de) 2001-12-13 2002-12-12 Vektorvermittelte organellentransfektion

Country Status (8)

Country Link
US (1) US7741112B2 (de)
EP (1) EP1463836B1 (de)
AT (1) ATE443158T1 (de)
AU (1) AU2002361649A1 (de)
DE (1) DE60233756D1 (de)
DK (1) DK1463836T3 (de)
ES (1) ES2333704T3 (de)
WO (1) WO2003052067A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2333704T3 (es) 2001-12-13 2010-02-26 University Of Virginia Patent Foundation Transfeccion de organulos mediada por un vector.
WO2005001062A2 (en) * 2003-06-25 2005-01-06 Gencia Corporation Modified vectors for organelle transfection
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
EP2418281B1 (de) 2003-10-24 2016-06-01 Gencia Corporation Verfahren und Zusammensetzungen zur Abgabe von Polynukleotiden
EP1751299B1 (de) 2004-05-26 2010-01-27 Anima Cell Metrology Verfahren zur auswertung von ribonukleotidsequenzen
GB0719367D0 (en) 2007-10-03 2007-11-14 Procarta Biosystems Ltd Transcription factor decoys, compositions and methods
WO2009047760A2 (en) 2007-10-09 2009-04-16 Anima Cell Metrology, Inc. Systems and methods for measuring translation activity in viable cells
CA2775231C (en) 2009-09-24 2018-06-05 Anima Cell Metrology, Inc. Systems and methods for measuring translation of target proteins in cells
GB201002413D0 (en) 2010-02-12 2010-03-31 Procarta Biosystems Ltd Nucleic acid complexes
GB201005545D0 (en) 2010-04-01 2010-05-19 Procarta Biosystems Ltd Transcription factor decoys
AU2015343307B2 (en) 2014-11-06 2021-05-20 Iff Us Holding, Llc Peptide-mediated delivery of RNA-guided endonuclease into cells
WO2018129440A1 (en) 2017-01-09 2018-07-12 University Of Massachusetts Complexes for gene deletion and editing

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855618A (en) * 1996-09-13 1999-01-05 Meadox Medicals, Inc. Polyurethanes grafted with polyethylene oxide chains containing covalently bonded heparin
US5854414A (en) * 1997-03-07 1998-12-29 Incyte Pharmaceuticals, Inc. Human mitochondrial membrane protein
US5831020A (en) * 1997-03-25 1998-11-03 The Research Foundation Of State University Of New York Protein-mediated nuclear import of DNA
US6368821B1 (en) * 1997-04-14 2002-04-09 Stratagene Process for infecting eukaryotic cells with a bacterial virus
WO2000023568A2 (en) 1998-10-06 2000-04-27 Albert Einstein College Of Medicine Of Yeshiva University Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells
CA2272788A1 (en) 1999-06-11 2000-12-11 Garching Innovation Gmbh Means and methods for transformation of plant mitochondria
ES2333704T3 (es) 2001-12-13 2010-02-26 University Of Virginia Patent Foundation Transfeccion de organulos mediada por un vector.

Also Published As

Publication number Publication date
ES2333704T3 (es) 2010-02-26
WO2003052067A3 (en) 2003-11-13
WO2003052067A2 (en) 2003-06-26
EP1463836A2 (de) 2004-10-06
US20070011759A1 (en) 2007-01-11
AU2002361649A8 (en) 2003-06-30
DK1463836T3 (da) 2010-01-18
DE60233756D1 (de) 2009-10-29
EP1463836B1 (de) 2009-09-16
EP1463836A4 (de) 2007-09-12
AU2002361649A1 (en) 2003-06-30
US7741112B2 (en) 2010-06-22

Similar Documents

Publication Publication Date Title
DK1463836T3 (da) Vektormedieret organeltransfektion
DK1395669T3 (da) Matriks bindingsregioner og fremgangsmåder til anvendelse af disse
FR10C0025I2 (fr) Protéines de fusion du récepteur de IL-1 utilisées comme antagonistes et méthodes d'utilisation et de fabrication
DE60234824D1 (de) Induzierbares expressionssystem in eukaryotischen zellen
ATA10002000A (de) Antigene zusammensetzung
ATE478965T1 (de) Lentivirusvektoren und deren verwendung
HK1093014A1 (en) Microsome vaccine
TW200611910A (en) Interferon-alpha polypeptides and conjugates
CY1114047T1 (el) Νεοι φορεις εκφρασης και χρησεις αυτων
CY1118782T1 (el) Επιλογη κυτταρων που εκφραζουν ετερομερη πολυπεπτιδια
CA2285667A1 (en) Viral vectors having chimeric envelope proteins containing the igg-binding domain of protein a
BR0212093A (pt) Quimeras de proteìna de envelope viral/receptor e métods de utilização
WO2007051063A3 (en) Gpcr expressing cell lines and antibodies
ATE306498T1 (de) Von zellen präsentierte peptide
ATE438727T1 (de) Optimierung von transgenexpression in säugetierzellen
DE60144021D1 (de) Für zellzyklusproteine kodierende nukleinsäure und deren verwendung
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
EP1702071A4 (de) Transaktivierungssystem für säugerzellen
ATE532861T1 (de) Expressionsvektor
DK1417222T3 (da) Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop
DE69534948D1 (de) Retrovirale vektoren zur expression in embryonalen zellen
DK1307569T3 (da) Fremstilling af rekombinant protein i en prokaryot værtscelle ved forbedret codonanvendelse
EE05691B1 (et) Ekspressioonivektorid ja nende rakendused
ATE338826T1 (de) Rekombinante virale vektoren zur tetracyclinregulierbaren genexpression
DK1634955T3 (da) Konditionale genvektorer, der er reguleret i cis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties